Evidence map›Paper›PMID 32649712›Full record

ArticlePloS one2020

Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study.

Elisa Pasqual, Michelle C Turner, Esther Gracia-Lavedan, Delphine Casabonne, Yolanda Benavente, Isabelle Thierry Chef, Marc Maynadié, Pierluigi Cocco, Anthony Staines, Lenka Foretova and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 8 countries.

Elisa PasqualBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.ORCID 0000-0001-7181-6160
Michelle C TurnerBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Esther Gracia-LavedanBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Delphine CasabonneCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Yolanda BenaventeCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Isabelle Thierry ChefBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Marc MaynadiéRegistre des Hémopathies Malignes de Côte d'Or INSERM U 1231, Université de Bourgogne Franche-Comté et CHU Dijon-Bourgogne, Dijon, France.
Pierluigi CoccoDepartment of Public Health, Clinical and Molecular Medicine, Occupational Health Section, University of Cagliari, Cagliari, Italy.
Anthony StainesSchool of Nursing and Human Science, Dublin City University, Glasnevin, Dublin, Ireland.ORCID 0000-0001-9161-1357
Lenka ForetovaCancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno, Czech Republic.
Alexandra NietersCentre of Chronic Immunodeficiency, Molecular Epidemiology, University Medical Center Freiburg, Freiburg, Germany.
Paolo BoffettaTisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Paul BrennanIARC, International Agency for Research on Cancer, Lyon, France.
Elisabeth CardisBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Silvia de SanjoseCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Universitat Pompeu Fabra · ESInstitut Català d'Oncologia · ESCentre international de recherche sur le cancer · FRDublin City University · IEIcahn School of Medicine at Mount Sinai · USInserm · FRMasaryk Memorial Cancer Institute · CZUniversity Medical Center Freiburg · DEUniversity of Cagliari · ITUniversity of Ottawa · CA

Funding

World Health Organization 001
6 · The paper itself

Abstract

Medical diagnostic X-rays are an important source of ionizing radiation (IR) exposure in the general population; however, it is unclear if the resulting low patient doses increase lymphoma risk. We examined the association between lifetime medical diagnostic X-ray dose and lymphoma risk, taking into account potential confounding factors, including medical history. The international Epilymph study (conducted in the Czech-Republic, France, Germany, Ireland, Italy, and Spain) collected self-reported information on common diagnostic X-ray procedures from 2,362 lymphoma cases and 2,465 frequency-matched (age, sex, country) controls. Individual lifetime cumulative bone marrow (BM) dose was estimated using time period-based dose estimates for different procedures and body parts. The association between categories of BM dose and lymphoma risk was examined using unconditional logistic regression models adjusting for matching factors, socioeconomic variables, and the presence of underlying medical conditions (atopic, autoimmune, infectious diseases, osteoarthritis, having had a sick childhood, and family history of lymphoma) as potential confounders of the association. Cumulative BM dose was low (median 2.25 mGy) and was not positively associated with lymphoma risk. Odds ratios (ORs) were consistently less than 1.0 in all dose categories compared to the reference category (less than 1 mGy). Results were similar after adjustment for potential confounding factors, when using different exposure scenarios, and in analyses by lymphoma subtype and by type of control (hospital-, population-based). Overall no increased risk of lymphoma was observed. The reduced ORs may be related to unmeasured confounding or other sources of systematic bias.We found little evidence that chronic medical conditions confound lymphoma risk and medical radiation associations.

Indexed as

Radiation, IonizingAdultAgedBone MarrowCase-Control StudiesFemaleHumansLogistic ModelsLymphomaMaleMiddle AgedOdds RatioRadiation DosageRadiation ExposureRisk Factors

Identifiers

PMID32649712
PMCPMC7351167
OpenAlexW3041484967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.